Stefanie Cavanaugh has more than 25 years of experience as a financial executive working in both public and private equity-sponsored growth-oriented healthcare products and services organizations. She currently serves as a public company board director for Aspira Women’s Health (NASDAQ: AWH) and as a private company CFO for Giving Home Health Care.

Stefanie qualifies as an audit committee financial expert providing extensive knowledge with public company reporting and investor relations requirements. She offers expertise and advice for capital market transactions having led numerous equity and debt financings in both public and private entities. Stefanie guides businesses scaling through high growth initiatives including merger and acquisition transactions and offers a unique perspective intersecting next generation direct patient care with transformative product development.

Stefanie presently serves as CFO for Giving Home Health Care having completed the $470 million acquisition of the company in August 2022 with private equity sponsorship. The strategic vision for Giving is to expand the current southwest region program providing home health services to former DOE employees to a national provider program.

From 2015 to 2021, Stefanie served as CFO of Apollo Endosurgery (NASDAQ:APEN) a medical device manufacturer focused on gastroenterology solutions. In addition to customary public company reporting, financial planning and capital formation duties, she completed Apollo’s IPO via a reverse merger transaction and managed the company’s $67 million acquisition of the Allergan health products division, establishing operations in the US, Europe, Australia, Brazil and Costa Rica. She has raised over $170 million in debt and equity financing to support well-defined strategic and organizational objectives.

From 2010 to 2014, Stefanie served as SVP Finance of Harden Healthcare, a private equity-backed company with $783 million in annual revenue offering senior healthcare services through seven operating entities. Harden was sold to Gentiva Healthcare for $427 million in 2014. During her tenure, Stefanie completed the $92 million acquisition of Voyager HospiceCare and five homecare acquisitions totaling $30 million, and negotiated a $195 million senior credit facility.

From 2008 to 2009, Stefanie served as CFO of Solis Women’s Health, a rapidly growing, acquisition focused radiology company. A key component of the company’s acquisition strategy was the transformation of acquired radiology centers from an analog to a digital platform. Stefanie developed and optimized this critical integration process to reduce the conversion timeline from six months to 60 days.

From 1998 to 2008, Stefanie was Corporate Controller of DJO (NASDAQ:DJO). Her tenure with the company coincided with the company’s growth from $35 million to $980 million in annual revenue through eleven acquisitions. In 2007, The Blackstone Group acquired the company for $900 million. Stefanie exited the company upon completion of a $1.6 billion merger with DJ Orthopedics.

Stefanie began her career with Ernst and Young in the Austin and San Antonio offices.

An active board member, Stefanie supports numerous charitable organizations currently serving on the Impact Austin finance committee and the Mainspring Schools Advisory Council.

Stefanie earned her BBA with a double major in accounting and finance from The University of Texas at Austin. She resides in Austin, Texas where she enjoys golf, the arts and spending time with her family.